Skip Nav Destination
Issues
1 January 2012
-
Cover Image
Cover Image
The expression of heat shock protein 25 (Hsp25) or Hsp27 in mouse and human breast cancer cells is effectively downregulated by Hsp25 short hairpin RNA (Hsp25shRNA) or Hsp27 small interfering RNA (Hsp27siRNA), respectively. The cover features phase-contrast (at left) and fluorescent (at right) micropictograms (40X magnification) of control 4T1 cells (a highly metastatic breast cancer cell line) expressing controlshRNA (top images) or 4T1 cells modified to express Hsp25shRNA (bottom images). As demonstrated by the phase-contrast images (left), cell morphology is unaffected by the permanent transduction of a vector which contains controlshRNA (which does not have any sequence homology with the mouse genome) or Hsp25shRNA (which has sequence homology with the mouse Hsp25 gene); the green fluorescent protein (GFP)-tagged fluorescent images (right) demonstrate a high expression (green) of controlshRNA and Hsp25shRNA even after six weeks in culture. Western blot analysis (not shown) indicates that Hsp25 expression is reduced in the Hsp25shRNAexpressing cells (bottom) versus controlshRNA-expressing cells (top). See article by Nagaraja et al. (beginning on page 122) for more information. - PDF Icon PDF LinkTable of Contents
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Letter from the Editor
Minireviews
Commentaries
Perspective
Research Articles
The Effect of HIV and HPV Coinfection on Cervical COX-2 Expression and Systemic Prostaglandin E2 Levels
Daniel W. Fitzgerald; Karl Bezak; Oksana Ocheretina; Cynthia Riviere; Thomas C. Wright; Ginger L. Milne; Xi Kathy Zhou; Baoheng Du; Kotha Subbaramaiah; Erin Byrt; Matthew L. Goodwin; Arash Rafii; Andrew J. Dannenberg
Hops (Humulus lupulus) Inhibits Oxidative Estrogen Metabolism and Estrogen-Induced Malignant Transformation in Human Mammary Epithelial cells (MCF-10A)
L.P. Hemachandra; P. Madhubhani; R. Chandrasena; P. Esala; Shao-Nong Chen; Matthew Main; David C. Lankin; Robert A. Scism; Birgit M. Dietz; Guido F. Pauli; Gregory R.J. Thatcher; Judy L. Bolton
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.